BTIS
ANIP icon

BB&T Investment Services’s ANI Pharmaceuticals ANIP Stock Holding History

BB&T Investment Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$22K Hold
359
– – ﹤0.01% 773
2017
Q3 		$20K Hold
359
– – ﹤0.01% 717
2017
Q2 		$16K Buy
359
+113
+46% +$5.45K ﹤0.01% 701
2017
Q1 		$12K Buy
246
+206
+515% +$11.6K ﹤0.01% 679
2016
Q4 		$2K Buy
+40
New +$2.45K ﹤0.01% 680

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BB&T Investment Services's ANIP Position: Q4 2017 in Review

BB&T Investment Services held its ANI Pharmaceuticals (ANIP) position steady in Q4 2017 at 359 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #773.

BB&T Investment Services first reported a position in ANIP in Q4 2016 and has held it in 5 quarters since. 163 funds tracked by Wall St. Rank hold ANIP as of Q4 2017.

  • BB&T Investment Services held 359 shares of ANI Pharmaceuticals worth $22K as of Q4 2017.
  • BB&T Investment Services left its ANI Pharmaceuticals share count unchanged in Q4 2017.
  • ANI Pharmaceuticals made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #773 holding.
  • BB&T Investment Services first reported a position in ANI Pharmaceuticals in Q4 2016 and has held it in 5 quarters since.
  • 163 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.